Medtronic shares owned by AQR Capital Management
Quarter-by-quarter ownership of Medtronic (MDT) shares owned by AQR Capital Management
from 13F filings
Historical chart of AQR Capital Management investment in Medtronic
Tip: Access up to 7 years of quarterly data
All positions including Medtronic held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Medtronic by AQR Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $191M | 2.1M | 89.34 |
2024-06-30 | $114M | 1.4M | 78.53 |
2024-03-31 | $117M | 1.3M | 87.15 |
2023-12-31 | $88M | 1.1M | 82.31 |
2023-09-30 | $96M | 1.2M | 78.30 |
2023-06-30 | $95M | 1.1M | 88.10 |
2023-03-31 | $92M | 1.2M | 79.60 |
2022-12-31 | $136M | 1.8M | 77.20 |
2022-09-30 | $96M | 1.2M | 80.75 |
2022-06-30 | $98M | 1.1M | 89.47 |
2022-03-31 | $132M | 1.2M | 110.93 |
2021-12-31 | $141M | 1.4M | 103.45 |
2021-09-30 | $174M | 1.4M | 125.35 |
2021-06-30 | $174M | 1.4M | 124.07 |
2021-03-31 | $201M | 1.7M | 118.11 |
2020-12-31 | $204M | 1.8M | 115.81 |
2020-09-30 | $190M | 1.8M | 102.98 |
2020-06-30 | $223M | 2.5M | 89.29 |
2020-03-31 | $205M | 2.3M | 89.75 |
2019-12-31 | $324M | 2.9M | 112.62 |
2019-09-30 | $402M | 3.7M | 108.17 |
2019-06-30 | $430M | 4.4M | 97.28 |
2019-03-31 | $429M | 4.8M | 90.21 |
2018-12-31 | $267M | 2.9M | 90.96 |
2018-09-30 | $174M | 1.8M | 98.37 |
2018-06-30 | $104M | 1.2M | 85.61 |
2018-03-31 | $104M | 1.3M | 80.22 |
2017-12-31 | $73M | 900k | 80.75 |
2017-09-30 | $41M | 528k | 77.77 |
2017-06-30 | $65M | 732k | 88.75 |
2017-03-31 | $46M | 569k | 80.56 |
2016-12-31 | $60M | 838k | 71.23 |
2016-09-30 | $56M | 644k | 86.40 |
2016-06-30 | $43M | 495k | 86.77 |
2016-03-31 | $38M | 502k | 75.00 |
2015-12-31 | $33M | 425k | 76.92 |
2015-09-30 | $47M | 696k | 66.94 |
2015-06-30 | $86M | 1.2M | 74.10 |
2015-03-31 | $98M | 1.3M | 77.99 |
More positions owned by AQR Capital Management
Cigna Corp (CI)
View all positions for AQR Capital Management